Related Experiment Video
Updated: Jan 19, 2026
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
No Association between Estrogen Receptor-Β Rs4986938 and Cancer Risk: A Systematic Review and Meta-Analysis
Zhaofang Li1, Xiaoli Yang1, Rongqiang Zhang1
1Institute of Endemic Diseases and Key Laboratory of Trace Elements and Endemic Diseases, National Health Commission of the People's Republic of China, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, P.R. China.
Background:
The association between estrogen receptor-β (ESR2) rs4986938 polymorphism and the risk of various types of cancer have been investigated in previous studies. However, the results remained disputable. Here, we conducted a meta-analysis to investigate the association between ESR2 rs4986938 polymorphism and the risk of cancer.
Methods:
We searched for relevant articles collected by the PubMed, EMBASE, and Cochrane library up to March 30, 2018. The association was assessed using Odds ratios (ORs) and 95% confidence intervals (CIs).
Results:
The meta-analysis involved a total of 23 studies in 20 papers, including 24,334 cases and 31,707 controls. No significant association was detected between the rs4986938 polymorphism and cancer risk in the additive model (A compared with G: OR=0.97, 95% CI=0.92-1.02, P=0.20), dominant model (AA+AG compared with GG: OR=0.96, 95% CI=0.93-1.03, P=1.00), recessive model (AA compared with AG + GG: OR=0.94, 95% CI=0.86-1.03, P=0.18), heterozygous model (AG compared with GG: OR=0.97, 95% CI=0.94-1.01, P=0.14), and homozygous model (AA compared with GG: OR=0.96, 95% CI=0.87-1.06, P=0.39). Results of subgroup analysis stratified by ethnicity and cancer types further validated the results.
Conclusion:
We found no evidence of an association between rs4986938 and the risk of overall cancer.
Related Concept Videos
16:24Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
06:07Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
03:52Estrogen Receptor-Reporter Activity Assay to Screen Phytoestrogen Estrogenic Activity
01:35Types of Risk: Systematic Risk
Market risk refers to the possibility that the overall stock market will decline, impacting the value of all investments. This risk is often driven by macroeconomic factors such as economic recessions, financial crises, or global...
10:36Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer